Suspension dispersible tablets and preparation method
A dispersible tablet and suspension technology, which is applied in the direction of medical preparations containing active ingredients, pharmaceutical formulas, organic active ingredients, etc., can solve the problems of children's poor drug compliance, poor control of dosage, and inconvenient carrying, etc., to improve biological Utilization, convenient transportation and carrying, and good patient compliance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Example Embodiment
[0025] Example 1: Preparation of 200 cefixime suspension and dispersible tablets
[0026] Prescription: Cefixime 28.2g sucrose 35g
[0027] Xanthan gum 2.01g Sodium carboxymethyl cellulose 0.5g
[0028] Microcrystalline cellulose 23.8g crospovidone 5.0g
[0029] Aspartame 2.0g Strawberry powder flavor 2.0g
[0030] Micro powder silica gel 0.5g Magnesium stearate 1.0g
[0031] Preparation:
[0032] (1). Sift the cefixime, sucrose, and sodium carboxymethyl cellulose to mix uniformly, then add purified water, granulate with a stirring granulator, dry the wet granules in an oven, and pass the dry granules through a 30-mesh sieve. Then add xanthan gum and mix evenly to obtain suspended particles;
[0033] (2) Mix the suspended particles with the remaining auxiliary materials in the prescription uniformly to obtain a mixed powder.
[0034] (3). Press the mixed powder into tablets to obtain.
[0035] The tablet weighs about 500 mg and its hardness is 25 Newtons. The hardne...
Example Embodiment
[0038] Example 2: Preparation of 1000 desloratadine suspension and dispersible tablets
[0039] prescription:
[0040] Deloratadine 7.9g Precipitated silica 0.1g
[0041] Eudragit E1002.5g Mannitol 87.5g
[0042] Lactose 87.5g Xanthan Gum 5.25g
[0043] Sodium carboxymethyl cellulose 3.5g microcrystalline cellulose 105g
[0044] Crospovidone 21g Aspartame 10.5g
[0045] Sweet orange flavor 12.25g micro powder silica gel 3.5g
[0046] Magnesium stearate 3.5g
[0047] Preparation:
[0048] (1) Firstly, desloratadine coated granules are prepared by desloratadine, precipitated silica and Eudragit E100;
[0049] (2). Sieve mannitol, lactose, and sodium carboxymethyl cellulose and mix evenly, then add purified water, in a stirring granulator, dry in a wet granulator oven, pass through a 30-mesh sieve, and then add xanthogen The glue is evenly mixed to obtain suspension particles;
[0050] (3) Mix the above-mentioned suspension granules with the remaining excipients in the prescription and the deslo...
Example Embodiment
[0052] Example 3: Preparation of 1000 azithromycin pellets capsules
[0053] Use the following prescription::
[0054] Azithromycin 100g Acrylic resin IV 35g
[0055] 150g mannitol 200g lactose
[0056] Xanthan gum 7.5g Sodium carboxymethyl cellulose 5g
[0057] Microcrystalline cellulose 150g crospovidone 30g
[0058] Aspartame 15g sweet orange flavor 17.5g
[0059] Micronized silica gel 5g Magnesium stearate 5g
[0060] Preparation Process:
[0061] (1) Coating azithromycin with acrylic resin IV to obtain azithromycin coated particles;
[0062] (2). Sieve mannitol, lactose and sodium carboxymethyl cellulose and mix evenly, then add purified water, granulate in a stirring granulator, dry in a wet granulator, pass through a 30-mesh sieve, and then add yellow The raw gum is mixed uniformly to obtain suspension particles;
[0063] (3) Mix the above-mentioned azithromycin-coated granules with the suspension granules and the remaining excipients in the prescription uniformly, and compress them w...
PUM
Property | Measurement | Unit |
---|---|---|
Weight | aaaaa | aaaaa |
Hardness | aaaaa | aaaaa |
Hardness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap